| 1254473-64-7 Basic information More.. |
Product Name: | LY 2874455 | Synonyms: | LY 2874455;(R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol;4-[(1E)-2-[5-[(1R)-1-(3,5-Dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]-1H-pyrazole-1-ethanol;LY2874455/LY-2874455;4-[(1E)-2-[5-[(1R)-1-(3,5-Dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]ethenyl]-1H-pyrazole-1-ethanol LY2874455;(R,E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethan-1-ol;(R,E)-2-(4-(2-(5-(1-(3,5-Dichloropyridin-4-yl)-ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl);(E)-2-(4-(2-(5-(1-(3,5-DICHLOROPYRIDIN-4-YL)ETHOXY)-1H-INDAZOL-3-YL)VINYL)-1H-PYRAZOL-1-YL)ETHANOL | CAS: | 1254473-64-7 | MF: | C21H19Cl2N5O2 | MW: | 444.31 | EINECS: | | Mol File: | 1254473-64-7.mol | |
Use
LY2874455 is a pan-FGFR inhibitor with IC50 of 2.8 nM, 2.6 nM, 6.4 nM, and 6 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively, and also inhibits VEGFR2 activity with IC50 of 7 nM. Phase 1.
- LY2874455
-
- US $58.00-130.00 / mg
- 2024-11-19
- CAS:1254473-64-7
- Min. Order:
- Purity: 99.46%
- Supply Ability: 10g
- LY 2874455
-
- US $2.00 / kg
- 2019-07-06
- CAS:1254473-64-7
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 100kg
|
1254473-64-7
Recommend Suppliers |
|